Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Tampa General Hospital, Tampa, Florida Rush University Cancer Center, Chicago, Illinois Advocate Christ Medical Center, Oak Lawn, Illinois University Medical Center LSU, New Orleans, Louisiana Fox Chase Cancer Center, Philadelphia, Pennsylvania